Skip to main content
. 2020 Sep 18;12(9):890. doi: 10.3390/pharmaceutics12090890
PMOs periodic mesoporous organosilicas
BPMOs biodegradable periodic mesoporous organosilica nanoparticles
EPR enhanced permeability and retention
MSNs Mesoporous silica nanoparticles
CTAB cetyltrimethylammonium bromide
TEOS tetraalkoxysilane
HD hydrodynamic diameter
GSH glutathione
EDIS Ethylene-Bis(Propyl) Disulfide
MPMO Mixed PMO
DOX Doxorubicin
CAM Chick Chorioallantoic Membrane
PBS Phosphate-buffered saline
SBF simulated body fluid
DNR Daunorubicin
TEM transmission electron microscope
BTESPT bis-(triethoxysilylpropyl)tetrasulfide
PCMONSs Mesoporous Organosilica Nanosheets
HMONs hollow mesoporous organosilica nanocapsule
ICP Inductively coupled plasma
Cys-PMO cystamine-integrated periodic mesoporous organosilica
PTX Paclitaxel
His-PMO histidine-periodic mesoporous organosilicas
NC nanocomposite
SAMs self-assembled monolayers
SDU–HMS safranin–diurea bridged hybrid mesoporous organosilica
5-FU 5-fluorouracil
AZO-B Azobenzene linkers were condensed with aromatic benzene (B)
AZO-E Azobenzene linkers were condensed with aliphatic ethane (E)
NIRF near-infrared fluorescence
CuS Copper monosulfide
DMPy-PMO Disilylated 2,6-Dimethylpyridine-PMO
GMP gemcitabine monophosphate
PEG polyethylene glycol
MoS2 Molybdenum disulfide
FRET fluorescence resonance energy transfer
PDT photodynamic therapy
HPMOs hybrid hollow PMOs
HIFU high intensity focused ultrasound
MPMS 3-mercaptopropyltrimethoxysilane
MPDMS 3-mercaptopropyl(dimethoxy)methylsilane
NMR Nuclear magnetic resonance